Question Everything. See who's reporting it.

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Source: Times of India

The story in brief

The US is considering new tariffs on pharmaceutical imports from India and other countries, part of Trump's strategy to boost domestic manufacturing. Indian generics supply 47% of US prescriptions, saving $1.3 trillion over a decade. US Trade Representative Greer hinted at more tariffs, with the temporary 10% blanket tariff on imports set to expire later this week. The move comes amid broader trade tensions.

6 outletsSee what the other 5 outlets said

NEWXFree on Android and iPhone. Open in NEWX